ClinicalTrialsFinder

Mild, Moderate, or Severe Alzheimer's Disease Clinical Trials in Taipei

1 recruitingTaipei, Taiwan

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics (Hong Kong) Ltd.15 enrolled2 locationsNCT06745583